Impact of a mobile phone-based interactive voice response software on tuberculosis treatment outcomes in Uganda (CFL-TB): a protocol for a randomized controlled trial
This study seeks to determine the impact of IVRT-based MHI on TB treatment success (treatment completion and cure rates) in patients with TB receiving care at five public health facilities in Uganda.MethodsWe used a theory-based and human-centered design (HCD) to adapt an already piloted software to design “Call for life-TB” (CFL-TB), an MHI that utilizes IVRT to deliver adherence and appointment reminders and allows remote symptom reporting. This open-label, multicenter, randomized controlled trial (RCT), with nested qualitative and economic evaluation studies, will determine the impact of CFL-TB on TB treatme...
Source: Trials - June 13, 2021 Category: Research Source Type: clinical trials

Rapid Research in Diagnostics Development for TB Network
Condition:   Tuberculosis Interventions:   Diagnostic Test: FLOW-TB Next-generation LAM;   Diagnostic Test: TAM-TB;   Diagnostic Test: Host Response Cartridge;   Diagnostic Test: IChroma POC CRP;   Diagnostic Test: Breath sensor;   Diagnostic Test: Automated CXR (chest X-ray);   Diagnostic Test: Next-generat ion LAM;   Diagnostic Test: Oral swab Xpert Ultra;   Diagnostic Test: Xpert MTB cfDNA Cartridge...
Source: ClinicalTrials.gov - June 11, 2021 Category: Research Source Type: clinical trials

Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB)
Condition:   Tuberculosis, Pulmonary Interventions:   Biological: RUTI®;   Biological: Placebo Sponsor:   Archivel Farma S.L. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 9, 2021 Category: Research Source Type: clinical trials

Safety of doTBal ® in Patients With Tuberculosis: Conduction of an Intensive Pharmacovigilance Program
Condition:   Tuberculosis Intervention:   Drug: Rifampicin/ Isoniazid/ Pyrazinamide/ Ethambutol Sponsor:   Laboratorios Silanes S.A. de C.V. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2021 Category: Research Source Type: clinical trials

Impact of SARS-CoV-2/COVID-19 Related Pneumonia on Lung Function and Structure.
Conditions:   Covid19;   SARS-CoV Infection;   Pulmonary Function;   Pneumonia, Viral Intervention:   Sponsors:   National Institute for Tuberculosis and Lung Diseases, Poland;   Medical University of Warsaw Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2021 Category: Research Source Type: clinical trials

Safety of doTBal ® in Patients With Tuberculosis: Conduction of an Intensive Pharmacovigilance Program
Condition:   Tuberculosis Intervention:   Drug: Rifampicin/ Isoniazid/ Pyrazinamide/ Ethambutol Sponsor:   Laboratorios Silanes S.A. de C.V. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2021 Category: Research Source Type: clinical trials

Impact of SARS-CoV-2/COVID-19 Related Pneumonia on Lung Function and Structure.
Conditions:   Covid19;   SARS-CoV Infection;   Pulmonary Function;   Pneumonia, Viral Intervention:   Sponsors:   National Institute for Tuberculosis and Lung Diseases, Poland;   Medical University of Warsaw Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2021 Category: Research Source Type: clinical trials

Safety of doTBal ® in Patients With Tuberculosis: Conduction of an Intensive Pharmacovigilance Program
Condition:   Tuberculosis Intervention:   Drug: Rifampicin/ Isoniazid/ Pyrazinamide/ Ethambutol Sponsor:   Laboratorios Silanes S.A. de C.V. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2021 Category: Research Source Type: clinical trials

Impact of SARS-CoV-2/COVID-19 Related Pneumonia on Lung Function and Structure.
Conditions:   Covid19;   SARS-CoV Infection;   Pulmonary Function;   Pneumonia, Viral Intervention:   Sponsors:   National Institute for Tuberculosis and Lung Diseases, Poland;   Medical University of Warsaw Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2021 Category: Research Source Type: clinical trials

Safety of doTBal ® in Patients With Tuberculosis: Conduction of an Intensive Pharmacovigilance Program
Condition:   Tuberculosis Intervention:   Drug: Rifampicin/ Isoniazid/ Pyrazinamide/ Ethambutol Sponsor:   Laboratorios Silanes S.A. de C.V. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2021 Category: Research Source Type: clinical trials

Impact of SARS-CoV-2/COVID-19 Related Pneumonia on Lung Function and Structure.
Conditions:   Covid19;   SARS-CoV Infection;   Pulmonary Function;   Pneumonia, Viral Intervention:   Sponsors:   National Institute for Tuberculosis and Lung Diseases, Poland;   Medical University of Warsaw Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2021 Category: Research Source Type: clinical trials

Safety of doTBal ® in Patients With Tuberculosis: Conduction of an Intensive Pharmacovigilance Program
Condition:   Tuberculosis Intervention:   Drug: Rifampicin/ Isoniazid/ Pyrazinamide/ Ethambutol Sponsor:   Laboratorios Silanes S.A. de C.V. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2021 Category: Research Source Type: clinical trials

Impact of SARS-CoV-2/COVID-19 Related Pneumonia on Lung Function and Structure.
Conditions:   Covid19;   SARS-CoV Infection;   Pulmonary Function;   Pneumonia, Viral Intervention:   Sponsors:   National Institute for Tuberculosis and Lung Diseases, Poland;   Medical University of Warsaw Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2021 Category: Research Source Type: clinical trials

Safety of doTBal ® in Patients With Tuberculosis: Conduction of an Intensive Pharmacovigilance Program
Condition:   Tuberculosis Intervention:   Drug: Rifampicin/ Isoniazid/ Pyrazinamide/ Ethambutol Sponsor:   Laboratorios Silanes S.A. de C.V. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2021 Category: Research Source Type: clinical trials

Impact of SARS-CoV-2/COVID-19 Related Pneumonia on Lung Function and Structure.
Conditions:   Covid19;   SARS-CoV Infection;   Pulmonary Function;   Pneumonia, Viral Intervention:   Sponsors:   National Institute for Tuberculosis and Lung Diseases, Poland;   Medical University of Warsaw Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2021 Category: Research Source Type: clinical trials